Experimental cell therapy targets aggressive brain tumors

This early-stage study tests whether a new treatment using a patient's own immune cells, engineered to attack two specific targets on glioblastoma cells, is safe. It involves 9 adults with a newly diagnosed, aggressive form of glioblastoma who have completed radiation but show no signs of cancer returning. The main goal is to check for side effects and see if the treatment is feasible.